ORNA Trademark

Trademark Overview

On Monday, March 9, 2020, a trademark application was filed for ORNA with the United States Patent and Trademark Office. The USPTO has given the ORNA trademark a serial number of 88827351. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by Oroboros, Inc.. The ORNA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines

Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
orna

General Information

Serial Number88827351
Word MarkORNA
Filing DateMonday, March 9, 2020
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7249621
Registration DateTuesday, December 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2020

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines
Goods and ServicesScientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateSaturday, March 14, 2020
Primary Code005
First Use Anywhere DateSunday, April 30, 2023
First Use In Commerce DateSunday, April 30, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 14, 2020
Primary Code042
First Use Anywhere DateSunday, April 30, 2023
First Use In Commerce DateMonday, May 22, 2023

Trademark Owner History

Party NameORNA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameORNA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameOroboros, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameOroboros, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 14, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 13, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 26, 2023USE AMENDMENT FILED
Wednesday, July 26, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2023SOU EXTENSION 5 GRANTED
Wednesday, March 1, 2023SOU EXTENSION 5 FILED
Tuesday, April 4, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, April 4, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 4, 2023PETITION TO REVIVE-GRANTED
Tuesday, April 4, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, September 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022SOU EXTENSION 4 GRANTED
Thursday, September 1, 2022SOU EXTENSION 4 FILED
Wednesday, September 7, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, September 6, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, September 6, 2022PETITION TO REVIVE-GRANTED
Tuesday, September 6, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 1, 2022SOU EXTENSION 3 FILED
Tuesday, April 5, 2022NOTICE OF REVIVAL - E-MAILED
Monday, April 4, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, April 4, 2022PETITION TO REVIVE-GRANTED
Monday, April 4, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 1, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 1, 2021SOU EXTENSION 2 FILED
Wednesday, September 1, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 12, 2021SOU EXTENSION 1 GRANTED
Tuesday, February 23, 2021SOU EXTENSION 1 FILED
Wednesday, March 10, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 24, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 17, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 28, 2020ASSIGNED TO EXAMINER
Saturday, March 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 12, 2020NEW APPLICATION ENTERED

Related Keywords

orna pharmaceuticals biologics acid biosimilars therapeutics nucleic biotherapeutics medicines immune treatment